FDA squelches BPA ‘low dose’ theory

Data from the Food and Drug Administration adds weight to packaging industry claims of BPA’s fitness as a food-contact material.

An independent study conducted by a dozen FDA scientists, with funding from the FDA and National Institutes of Health (NIH) gave bisphenol-A to pregnant rats, then to their offspring for 90 days after birth. The pups exposed to the doses reportedly did not show any indication of ill health effects.

No ill effects

The study reported no effects of BPA at any dose, except at the very highest levels, and is consistent with the FDA’s current position that BPA is safe at the very low amounts that occur in some foods,”  FDA officials stated.

The peer-reviewed study has been hailed by packaging firms and industry associations as further evidence that BPA is safe for use in metal can linings, plastic containers, and other food-contact materials.

Industry response

John M. Rost, chairman of the North American Metal Packaging Association (NAMPA) said the study is merely the latest report in a long line of data supporting BPA’s fitness for use in food packaging.

“In yet another example of comprehensive research, performed by experts at FDA specifically to address concerns about health effects from low exposures to BPA, this latest work reinforces BPA’s safety,” he said. “What these scientists found should hopefully dispel the myth that BPA causes obesity, diabetes, heart disease, and other health effects.”

In November, a report by a group of scientists issued a report that claimed that the recommended BPA lowest observed adverse effect level (LOAEL) of 50 mg/kg/day was not sufficient to protect consumers. Read more about the scientists' report here.